骨髓纤维化和贫血:一项德国声称的数据分析描述了流行病学和当前的治疗方法
Alexander Slowley1, Sofie Weinmann2, Tim d'Estrube1
1GSK, Value, Evidence and Outcomes Europe, London, UK.
European journal of haematology
|August 5, 2024
概括
骨髓纤维化 (MF) 在德国每10万人中约有10-12人患病. 许多MF患者需要治疗贫血,这表明需要改善护理和生活质量.
科学领域:
- 血液学 血液学 血液学
- 流行病学 流行病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 骨髓纤维化 (MF) 是一种严重的骨髓扩散性瘤,在德国流行病学数据有限.
- 了解MF的发生率,流行率和治疗模式对于医疗保健规划至关重要.
研究的目的:
- 利用医疗保险索赔数据,确定德国骨髓纤维化 (MF) 的发病率和流行率.
- 评估MF的治疗环境,包括Janus激酶抑制剂 (JAKi) 疗法和贫血管理.
主要方法:
- 对德国330万个人 (2010-2021) 的索赔数据的回顾性分析.
- 利用四个敏感性场景来定义MF病例.
- 2021年MF及其治疗方法的计算点和累积发病率以及周期流行率.
主要成果:
- 据估计,截至2021年12月31日,每10万人中MF的标准化点患病率为9.9-12.4.
- 2021年的累积发病率为每10万人中1.2-1.8.
- 接受一线 (1L) 或二线 (2L+) Janus 激酶抑制剂 (JAKi) 治疗的MF患者的周期患病率为每10万人中4.0;这些患者中的47.1%-53.7%也需要贫血治疗.
结论:
- 该研究强调了德国当前骨髓纤维化治疗方案中的重大缺陷.
- 显然需要通过优化MF和相关贫血的治疗策略来提高患者的生活质量.
相关概念视频
Erythropoiesis
4.1K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Bone Marrow Sampling and Transplants
317
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
317
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


